MedPath

An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis

Not Applicable
Active, not recruiting
Conditions
Endometriosis
Interventions
Other: AHEI diet
Registration Number
NCT04259788
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

The investigators are conducting this study to examine if a healthy diet based on the Alternative Healthy Eating Index (AHEI) influences pain symptoms, quality of life, and inflammatory markers measured in blood samples in women with endometriosis who are currently experiencing pain symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
109
Inclusion Criteria
  • Female
  • Aged 18-45
  • Laparoscopically-confirmed endometriosis
  • Premenopausal (at least one period in the past 6 months)
  • VAS pain score of at least 7 out of 10 in the previous 3 months
  • Score below 75 on the AHEI-2010
Exclusion Criteria
  • Postmenopausal
  • Pregnant
  • Have had a hysterectomy or oophorectomy
  • Have chronic illnesses that are known to affect gastrointestinal absorption of nutrients (celiac disease, Crohn's disease, ulcerative colitis, or cystic fibrosis)
  • A history of kidney stones, cancer (except basal cell carcinoma), or diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionAHEI dietThe intervention group will receive in-person dietary counseling from a registered dietitian to help participants consume a diet that is consistent the AHEI dietary guidelines. Participants in this arm will be asked to consume this diet for a 12-week period and discontinue any vitamin or supplement intake during this time. During the first 4 weeks 2 meals and 1 snack/day will be shipped to the participant. During the last 8 weeks of the intervention, the study will provide the participants with a 14-day meal plan (3 meals and 2 snacks) that adheres to the AHEI maximum score criteria to help facilitate adherence to the diet.
Primary Outcome Measures
NameTimeMethod
Quality of Life QuestionnaireWeek 12

Physical and mental QOL components will be measured with the Endometriosis Health Profile Questionnaire. Scores range from 0 to 100, higher scores reflect more symptoms and worse health status.

Pain MeasurementWeek 12

Pain will be measured with components of the EPHect participant questionnaire using the mean number of analgesic and/or opioid pills taken per week.

Quality of Life SurveyWeek 12

Physical and mental QOL components will be measured with the Short Form-12 survey. There are two components, a physical component summary (PCS) and a mental health component summary (MCS). Both have a range of 0 to 100, higher scores represent better health.

Tumor Necrosis Factor MeasurementWeek 12

Measurement of circulating levels of soluble tumor necrosis factor (TNF) alpha-receptor 1.

Inflammatory MarkersWeek 8

Measurement of circulating levels of inflammatory markers (interleukin (IL)-6 and IL-1β.

Protein MeasurementWeek 12

Measurement of circulating levels of high sensitivity-C-reactive protein.

Tumor Necrosis Factor Measurement #2Week 12

Measurement of circulating levels of soluble TNF alpha-receptor 2.

inflammatory MarkersWeek 12

Measurement of circulating levels of inflammatory markers (interleukin (IL)-6 and IL-1β.

Secondary Outcome Measures
NameTimeMethod
Pain Measurement12 months

Pain will be measured with components of the EPHect participant questionnaire using the VAS pain score. Scores range from 0 to 10, higher score is more pain (worse).

Qualify of Life Questionnaire6 months

Physical and mental QOL components will be measured with the Endometriosis Health Profile Questionnaire. Scores range from 0 to 100, higher scores reflect more symptoms and worse health status.

Quality of Life Questionnaire12 months

Physical and mental QOL components will be measured with the Endometriosis Health Profile Questionnaire. Scores range from 0 to 100, higher scores reflect more symptoms and worse health status.

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath